A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Pharmacokinetics Of Pf 04958242 In Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 02 Jul 2016
At a glance
- Drugs PF 4958242 (Primary) ; Itraconazole
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 23 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 22 Jan 2015 New trial record